RNA Interference News and Research

RSS
Egg yolk precursor protein plays key role in regulating mosquitos’ attraction to humans

Egg yolk precursor protein plays key role in regulating mosquitos’ attraction to humans

Study describes vulnerability shared by large subset of cancer cell lines

Study describes vulnerability shared by large subset of cancer cell lines

Large-scale screen efficiently identifies drugs that are potent cancer-killers

Large-scale screen efficiently identifies drugs that are potent cancer-killers

Liver tissue model can help investigate the effects of RNA interference

Liver tissue model can help investigate the effects of RNA interference

Researchers outline targeted therapeutic strategy for triple-negative breast cancer

Researchers outline targeted therapeutic strategy for triple-negative breast cancer

New acute porphyria treatment shows promising results in clinical study

New acute porphyria treatment shows promising results in clinical study

RBSC announces partnership with Mitacs to develop and test yeast-based RNAi technology

RBSC announces partnership with Mitacs to develop and test yeast-based RNAi technology

Study shows an unusual mechanism could have thwart the invasion of human genome by junk DNA

Study shows an unusual mechanism could have thwart the invasion of human genome by junk DNA

Protein discovery could lead to mosquito "birth control"

Protein discovery could lead to mosquito "birth control"

Inhalable mRNA offers hope for patients with lung disease

Inhalable mRNA offers hope for patients with lung disease

Genetically modified pigs could limit replication of classical swine fever virus, study shows

Genetically modified pigs could limit replication of classical swine fever virus, study shows

UT Southwestern researchers discover enzyme that promotes tumor growth

UT Southwestern researchers discover enzyme that promotes tumor growth

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

New initiative may benefit entrepreneurs working to transform patient care

New initiative may benefit entrepreneurs working to transform patient care

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam reports further progress on broadening the therapeutic potential of RNAi

Alnylam reports further progress on broadening the therapeutic potential of RNAi

Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

Arrowhead completes dosing of ARO-AAT Phase 1 study to treat rare genetic liver disease

Arrowhead completes dosing of ARO-AAT Phase 1 study to treat rare genetic liver disease

EC grants marketing authorization for ONPATTRO (patisiran) in Europe

EC grants marketing authorization for ONPATTRO (patisiran) in Europe